Greater Midwest Financial Group LLC trimmed its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,482 shares of the company’s stock after selling 72 shares during the period. Greater Midwest Financial Group LLC’s holdings in McKesson were worth $845,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of the stock. Thrivent Financial for Lutherans boosted its holdings in McKesson by 5.5% during the second quarter. Thrivent Financial for Lutherans now owns 19,036 shares of the company’s stock worth $11,117,000 after buying an additional 998 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in shares of McKesson by 76.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 4,778 shares of the company’s stock worth $2,791,000 after acquiring an additional 2,064 shares in the last quarter. Insigneo Advisory Services LLC grew its position in shares of McKesson by 25.8% during the 2nd quarter. Insigneo Advisory Services LLC now owns 804 shares of the company’s stock valued at $493,000 after acquiring an additional 165 shares during the period. AQR Capital Management LLC increased its stake in shares of McKesson by 7.9% in the 2nd quarter. AQR Capital Management LLC now owns 857,611 shares of the company’s stock valued at $500,879,000 after purchasing an additional 62,875 shares in the last quarter. Finally, APG Asset Management US Inc. raised its holdings in McKesson by 2.1% in the 2nd quarter. APG Asset Management US Inc. now owns 63,727 shares of the company’s stock worth $37,366,000 after purchasing an additional 1,310 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at McKesson
In related news, EVP Leann B. Smith sold 579 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total transaction of $331,645.41. Following the completion of the transaction, the executive vice president now owns 864 shares of the company’s stock, valued at approximately $494,890.56. This trade represents a 40.12 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.11% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on MCK
McKesson Trading Up 2.2 %
Shares of MCK opened at $597.31 on Friday. The firm has a 50-day moving average price of $593.20 and a 200 day moving average price of $561.23. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The firm has a market capitalization of $75.82 billion, a P/E ratio of 30.93, a P/E/G ratio of 1.26 and a beta of 0.52.
McKesson (NYSE:MCK – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The business had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter last year, the firm earned $6.23 EPS. The business’s revenue was up 21.3% compared to the same quarter last year. Equities research analysts predict that McKesson Co. will post 32.73 earnings per share for the current fiscal year.
McKesson Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Monday, December 2nd were paid a $0.71 dividend. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. The ex-dividend date of this dividend was Monday, December 2nd. McKesson’s dividend payout ratio (DPR) is presently 14.71%.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- Canada Bond Market Holiday: How to Invest and Trade
- Despite Short-Term Risks Freeport McMoran Worth a Look
- Upcoming IPO Stock Lockup Period, Explained
- 3 Lean and Mean Stocks Generating Over $1M in Revenue Per Worker
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- The Next Big Thing in AI: 2 Edge Computing Chipmakers to Watch
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.